Eikon Therapeutics, Inc. · NASDAQ:EIKN
FMR LLC reported a 7.10% stake in Eikon Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 6, 2026
FMR LLC reported a 7.10% stake in Eikon Therapeutics, Inc., 3,836,830 shares, as a passive investor on Mar 31, 2026. Filed May 6, 2026 (Schedule 13G).
- Stake
- 7.10%
- Shares
- 3,836,830
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| FMR LLC | 7.10% | 3,836,830 |
| Abigail P. Johnson | 7.10% | 3,836,830 |
Source
Related
- Eikon Therapeutics, Inc.
- FMR LLC
- Eikon Therapeutics, Inc. shareholders
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13G/A · Abu Dhabi Investment Authority · Oct 2, 2026
- Form 4 · Kutzkey Tim · Sep 8, 2026
- Schedule 13G · Innovation Endeavors III LP · May 15, 2026
- Schedule 13G · Perlmutter Roger M · May 13, 2026
- Schedule 13G · BlackRock Portfolio Management LLC · Apr 29, 2026